Cargando…
Therapeutic utility of engineered myeloid cells in the tumor microenvironment
Despite promising results shown in hematologic tumors, immunotherapies for the treatment of solid tumors have mostly failed so far. The immunosuppressive tumor microenvironment and phenotype of tumor infiltrating macrophages are among the more prevalent reasons for this failure. Tumor associated mac...
Autores principales: | Canella, Alessandro, Rajappa, Prajwal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353932/ https://www.ncbi.nlm.nih.gov/pubmed/36854896 http://dx.doi.org/10.1038/s41417-023-00600-7 |
Ejemplares similares
-
DIPG-16. Evaluation of myeloid component of DIPG microenvironment
por: Mishra, Deepak, et al.
Publicado: (2022) -
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
por: Achyut, Bhagelu R, et al.
Publicado: (2016) -
The Metabolic Control of Myeloid Cells in the Tumor Microenvironment
por: Ramel, Eloise, et al.
Publicado: (2021) -
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
por: Frosch, Jennifer, et al.
Publicado: (2021) -
Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
por: Schmid, Michael C., et al.
Publicado: (2010)